AU2002317063A1 - Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same - Google Patents
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing sameInfo
- Publication number
- AU2002317063A1 AU2002317063A1 AU2002317063A AU2002317063A AU2002317063A1 AU 2002317063 A1 AU2002317063 A1 AU 2002317063A1 AU 2002317063 A AU2002317063 A AU 2002317063A AU 2002317063 A AU2002317063 A AU 2002317063A AU 2002317063 A1 AU2002317063 A1 AU 2002317063A1
- Authority
- AU
- Australia
- Prior art keywords
- granulations
- itraconazole
- oral administration
- pharmaceutical formulations
- preparing same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- VHVPQPYKVGDNFY-TUJWMRSMSA-N 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-TUJWMRSMSA-N 0.000 title 1
- 230000003179 granulation Effects 0.000 title 1
- 229960004130 itraconazole Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29726001P | 2001-06-12 | 2001-06-12 | |
| US60/297,260 | 2001-06-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002317063A1 true AU2002317063A1 (en) | 2002-12-23 |
| AU2002317063A AU2002317063A (en) | 2002-12-23 |
Family
ID=23145542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002317063A Withdrawn AU2002317063A (en) | 2001-06-12 | 2002-06-12 | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002317063A (en) |
| WO (1) | WO2002100407A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100557680B1 (en) * | 2002-11-23 | 2006-03-07 | 한국유나이티드제약 주식회사 | Pellet preparations and methods for improved solubility of itraconazole |
| US20050255157A1 (en) * | 2004-05-11 | 2005-11-17 | Glenmark Pharmaceuticals Limited | Sustained release, mucoadhesive vaginal pharmaceutical compositions |
| GB0428152D0 (en) * | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| DE102008047910A1 (en) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tabletting excipient based on lactose and cellulose |
| CN109172532A (en) * | 2018-10-24 | 2019-01-11 | 北京哈三联科技有限责任公司 | A kind of itraconazole dispersible tablets and its preparation method and application |
| WO2022264004A1 (en) * | 2021-06-13 | 2022-12-22 | Glenmark Pharmaceutical Limited | Pharmaceutical composition comprising itraconazole |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199801225T2 (en) * | 1996-05-20 | 1998-11-23 | Janssen Pharmaceutica N.V. | Antifungal compounds with enhanced bioavailability. |
| RU2218153C2 (en) * | 1997-03-26 | 2003-12-10 | Жансен Фармасетика Н.В. | Nucleus-bearing drops coated with antifungal agent and polymer |
| KR19990001564A (en) * | 1997-06-16 | 1999-01-15 | 유충식 | Azole antifungal agents with improved solubility and preparations containing them |
| WO1999033467A1 (en) * | 1997-12-31 | 1999-07-08 | Choongwae Pharma Corporation | Method and composition of an oral preparation of itraconazole |
-
2002
- 2002-06-12 AU AU2002317063A patent/AU2002317063A/en not_active Withdrawn
- 2002-06-12 WO PCT/CA2002/000894 patent/WO2002100407A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002357012A1 (en) | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof | |
| HUP0402451A3 (en) | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules | |
| HUP0101246A3 (en) | Novel galenic formulations of meloxicam for oral administration and process for their preparation | |
| HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
| AU2002352974A1 (en) | Formulations for oral administration of cromolyn sodium | |
| HK1072898A1 (en) | Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles | |
| HUP0303800A3 (en) | Pharmaceuticals and dosage forms of epothilones for oral administration | |
| PL396568A1 (en) | Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate | |
| AU2001230892A1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same | |
| HUP0400281A3 (en) | Pharmaceutical compositions of adsorbates of amorphous drug and process for their preparation | |
| HUP0203451A3 (en) | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation | |
| GB0100758D0 (en) | Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control | |
| AU2001226029A1 (en) | Pharmaceutical formulation and method for pulmonary and oral delivery | |
| WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
| IL166489A (en) | Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof | |
| AU2002216701A1 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
| PL356358A1 (en) | Solid dosage form of someticone for oral administration | |
| AU2001283563A1 (en) | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent | |
| HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
| AU2003277710A1 (en) | Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same | |
| IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
| AU2001258395A1 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| AU2002317063A1 (en) | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same | |
| AU2002317063A (en) | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same | |
| HUP0500958A3 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them |